guanfacine
Selected indexed studies
- Guanfacine for the Treatment of Attention-Deficit Hyperactivity Disorder: An Updated Systematic Review and Meta-Analysis. (J Child Adolesc Psychopharmacol, 2023) [PMID:36944092]
- Guanfacine Use in the ICU for Management of Sedation Weaning. (Clin Drug Investig, 2025) [PMID:40072723]
- Guanfacine's mechanism of action in treating prefrontal cortical disorders: Successful translation across species. (Neurobiol Learn Mem, 2020) [PMID:33075480]
_Worker-drafted node — pending editorial review._
Connections
guanfacine is a side effect of
Sources
- Guanfacine for the Treatment of Attention-Deficit Hyperactivity Disorder: An Updated Systematic Review and Meta-Analysis. (2023) pubmed
- Guanfacine Use in the ICU for Management of Sedation Weaning. (2025) pubmed
- Guanfacine's mechanism of action in treating prefrontal cortical disorders: Successful translation across species. (2020) pubmed
- Pharmacologic Treatment of Attention Deficit-Hyperactivity Disorder. (2020) pubmed
- Guanfacine extended-release for attention-deficit/hyperactivity disorder (ADHD). (2010) pubmed
- Guanfacine extended-release: in attention deficit hyperactivity disorder. (2010) pubmed
- Evaluating Guanfacine Hydrochloride in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Adult Patients: Design, Development and Place in Therapy. (2021) pubmed
- Nonstimulant Treatments for ADHD. (2022) pubmed
- Guanfacine extended release in the treatment of attention deficit hyperactivity disorder in children and adolescents. (2010) pubmed
- Guanfacine and guanfacine extended release: treatment for ADHD and related disorders. (2007) pubmed